Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation.

Autor: Percival ME; Division of Hematology, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. mperciva@seattlecca.org., Wang HL; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Zhang MJ; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI, USA., Saber W; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., de Lima M; Department of Medicine, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USA., Litzow M; Division of Hematology and Transplant Center, Mayo Clinic Rochester, Rochester, MN, USA., Kebriaei P; Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Abdel-Azim H; Division of Hematology, Oncology and Blood & Marrow Transplantation, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA., Adekola K; Division of Hematology and Oncology, Department of Medicine and Robert H. Lurie Comprehensive Cancer, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Aljurf M; Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia., Bacher U; Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Badawy SM; Division of Hematology, Oncology and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Beitinjaneh A; University of Miami, Miami, FL, USA., Bejanyan N; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA., Bhatt V; The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA., Byrne M; Vanderbilt University Medical Center, Nashville, TN, USA., Cahn JY; Department of Hematology, CHU Grenoble Alpes, Grenoble, France., Castillo P; UF Health Shands Children's Hospital, Gainesville, FL, USA., Chao N; Department of Medicine, Division of Cell Therapy and Hematology, Duke University Medical Center, Durham, NC, USA., Chhabra S; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.; Department of Medicine, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA., Copelan E; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Cutler C; Center for Hematologic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., DeFilipp Z; Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA, USA., Dias A; Beth Israel Deaconess Medical Center, Westwood, KS, USA., Diaz MA; Department of Hematology/Oncology, Hospital Infantil Universitario Nino Jesus, Madrid, Spain., Estey E; Division of Hematology, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Farhadfar N; Division of Hematology and Oncology, University of Florida College of Medicine, Gainesville, FL, USA., Frangoul HA; The Children's Hospital at TriStar Centennial and Sarah Cannon Research Institute, Nashville, TN, USA., Freytes CO; Texas Transplant Institute, San Antonio, TX, USA., Gale RP; Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, UK., Ganguly S; Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City, KS, USA., Gowda L; Yale New Haven Hospital, New Haven, CT, USA., Grunwald M; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Hossain N; Department of Medicine, Division of Hematology and Oncology, Stem Cell Transplant Program-Loyola University Stritch School of Medicine, Maywood, IL, USA., Kamble RT; Center for Cell and Gene Therapy, Division of Hematology and Oncology, Baylor College of Medicine, Houston, TX, USA., Kanakry CG; Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Kansagra A; UT Southwestern Medical Center-BMT Program, Dallas, TX, USA., Kharfan-Dabaja MA; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA., Krem M; University of Louisville Hospital/James Brown Cancer Center, Louisville, KY, USA., Lazarus HM; University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA., Lee JW; Division of Hematology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea., Liesveld JL; Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA., Lin R; Memorial Sloan Kettering Cancer Center-Adults, New York, NY, USA., Liu H; University of Chicago Medicine, Chicago, IL, USA., McGuirk J; University of Kansas, Westwood, KS, USA., Munker R; Markey Cancer Center, University of Kentucky, Lexington, KY, USA., Murthy HS; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA., Nathan S; Rush University Medical Center, Chicago, IL, USA., Nishihori T; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA., Olsson RF; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.; Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden., Palmisiano N; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA., Passweg JR; University Hospital Basel, Basel, Switzerland., Prestidge T; Blood and Cancer Centre, Starship Children's Hospital, Auckland, New Zealand., Ringdén O; Translational Cell Therapy Group, CLINTEC (Clinical Science, Intervention and Technology), Karolinska Institutet, Stockholm, Sweden., Rizzieri DA; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA., Rybka WB; Penn State Hershey Medical Center, Hershey, PA, USA., Savoie ML; Tom Baker Cancer Centre, Calgary, AB, Canada., Schultz KR; Department of Pediatric Hematology, Oncology and Bone Marrow Transplant, British Columbia's Children's Hospital, The University of British Columbia, Vancouver, BC, Canada., Seo S; Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan., Sharma A; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA., Solh M; The Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, GA, USA., Strair R; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA., van der Poel M; Maastricht University Medical Centre, Maastricht, The Netherlands., Verdonck LF; Department of Hematology/Oncology, Isala Clinic, Zwolle, The Netherlands., Yared JA; Blood & Marrow Transplantation Program, Department of Medicine, Division of Hematology and Oncology, Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, USA., Weisdorf D; Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA.; CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN, USA., Sandmaier BM; Division of Medical Oncology, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2021 Sep; Vol. 56 (9), pp. 2108-2117. Date of Electronic Publication: 2021 Apr 16.

Incorporation of posttransplant cyclophosphamide as part of standard immunoprophylaxis for all allogeneic transplants: a retrospective, single institution study.

Autor: Cooper DL; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. dc1073@cinj.rutgers.edu., Manago J; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Patel V; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Schaar D; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Krimmel T; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., McGrath MK; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Tyno A; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Lin Y; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Strair R; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2021 May; Vol. 56 (5), pp. 1099-1105. Date of Electronic Publication: 2020 Dec 01.

Antibody-Based Therapies for Peripheral T-Cell Lymphoma.

Autor: Shafagati, Nazila¹ (AUTHOR) nshafag1@jhu.edu, Paul, Suman¹ (AUTHOR), Rozati, Sima¹ (AUTHOR), Sterling, Cole H.¹ (AUTHOR) nshafag1@jhu.edu

Publikováno v: Cancers. Oct2024, Vol. 16 Issue 20, p3489. 22p.

Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.

Autor: Im A; University of Pittsburgh/UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania., Rashidi A; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota., Wang T; Department of Medicine, Medical College of Wisconsin, CIBMTR® (Center for International Blood and Marrow Transplant Research), Milwaukee, Wisconsin; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin., Hemmer M; Department of Medicine, Medical College of Wisconsin, CIBMTR® (Center for International Blood and Marrow Transplant Research), Milwaukee, Wisconsin., MacMillan ML; Blood and Marrow Transplant Program, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota., Pidala J; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Jagasia M; Vanderbilt University Medical Center, Nashville, Tennessee., Pavletic S; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Majhail NS; Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio., Weisdorf D; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota., Abdel-Azim H; (0)Division of Hematology, Oncology and Blood & Marrow Transplantation, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California., Agrawal V; Division of Hematology-Oncology, Indiana University School of Medicine, Indianapolis, Indiana., Al-Homsi AS; (2)New York University Langone Medical Center, New York, New York., Aljurf M; (3)Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia., Askar M; (4)Department of Pathology and Laboratory Medicine, Baylor University Medical Center, Dallas, Texas., Auletta JJ; (5)Blood and Marrow Transplant Program and Host Defense Program, Divisions of Hematology/Oncology/Bone Marrow Transplant and Infectious Diseases, Nationwide Children's Hospital, Columbus, Ohio., Bashey A; (6)Blood and Marrow Transplant Program at Northside Hospital, Atlanta, Georgia., Beitinjaneh A; (7)Department of Hematology and Oncology, University of Miami, Miami, Florida., Bhatt VR; (8)The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska., Byrne M; Vanderbilt University Medical Center, Nashville, Tennessee., Cahn JY; Department of Hematology, CHU Grenoble Alpes, Grenoble, France., Cairo M; (0)Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, New York Medical College, Valhalla, New York., Castillo P; (1)UF Health Shands Children's Hospital, Gainesville, Florida., Cerny J; Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical Center, Worcester, Massachusetts., Chhabra S; Department of Medicine, Medical College of Wisconsin, CIBMTR® (Center for International Blood and Marrow Transplant Research), Milwaukee, Wisconsin., Choe H; (3)James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, Ohio., Ciurea S; (4)The University of Texas MD Anderson Cancer Center, Houston, Texas., Daly A; (5)Tom Baker Cancer Center, Calgary, Alberta, Canada., Perez MAD; (6)Department of Hematology/Oncology, Hospital Infantil Universitario Nino Jesus, Madrid, Spain., Farhadfar N; (7)Division of Hematology/Oncology, University of Florida College of Medicine, Gainesville, Florida., Gadalla SM; (8)Division of Cancer Epidemiology & Genetics, NIH-NCI Clinical Genetics Branch, Rockville, Maryland., Gale R; Hematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, United Kingdom., Ganguly S; (0)Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City, Kansas., Gergis U; (1)Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania., Hanna R; (2)Cleveland Clinic Foundation, Cleveland, Ohio., Hematti P; Division of Hematology/Oncology/Bone Marrow Transplantation, Department of Medicine, University of Wisconsin, Madison, Wisconsin., Herzig R; (4)University of Kentucky Chandler Medical Center, Louisville, Kentucky., Hildebrandt GC; (5)Markey Cancer Center, University of Kentucky, Lexington, Kentucky., Lad DP; (6)Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India., Lee C; (7)Utah Blood and Marrow Transplant Program at Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Lehmann L; (8)Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts., Lekakis L; (7)Department of Hematology and Oncology, University of Miami, Miami, Florida., Kamble RT; Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas., Kharfan-Dabaja MA; (0)Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida., Khandelwal P; (1)Division of Bone Marrow Transplant and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; (2)Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio., Martino R; (3)Divison of Clinical Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Murthy HS; (0)Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida., Nishihori T; Department of Blood & Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, Florida., O'Brien TA; (5)Blood & Marrow Transplant Program, Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia., Olsson RF; (6)Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; (7)Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden., Patel SS; (8)Blood and Marrow Transplant Program, University of Utah, Salt Lake City, Utah., Perales MA; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Prestidge T; (0)Blood and Cancer Centre, Starship Children's Hospital, Auckland, New Zealand., Qayed M; (1)Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia., Romee R; (2)Dana Farber Cancer Institute, Boston, Massachusetts., Schoemans H; (3)Department of Hematology, University Hospitals Leuven and KU Leuven, Leuven, Belgium., Seo S; (4)Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan., Sharma A; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee., Solh M; (6)The Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, Georgia., Strair R; (7)Rutgers Cancer Institute of New Jersey, Rutgers University, Brunswick, New Jersey., Teshima T; (8)Hokkaido University Hospital, Sapporo, Japan., Urbano-Ispizua A; Department of Hematology, Hospital Clinic, University of Barcelona, IDIBAPS, and Institute of Research Josep Carreras, Barcelona, Spain., Van der Poel M; (0)Maastricht University Medical Center, Maastricht, the Netherlands., Vij R; (1)Division of Hematology and Oncology, Washington University School of Medicine, St. Louis, Missouri., Wagner JL; (2)Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania., William B; (3)Division of Hematology, The Ohio State University, Columbus, Ohio., Wirk B; (4)Bone Marrow Transplant Program, Penn State Cancer Institute, Hershey, Pennsylvania., Yared JA; (5)Blood & Marrow Transplantation Program, Division of Hematology/Oncology, Department of Medicine, Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, Maryland., Spellman SR; Department of Medicine, Medical College of Wisconsin, CIBMTR® (Center for International Blood and Marrow Transplant Research), Milwaukee, Wisconsin., Arora M; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota., Hamilton BK; Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio. Electronic address: hamiltb2@ccf.org.

Publikováno v: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 Aug; Vol. 26 (8), pp. 1459-1468. Date of Electronic Publication: 2020 May 17.

Common Driver Mutations in AML: Biological Impact, Clinical Considerations, and Treatment Strategies.

Autor: Nong, Tiffany¹ (AUTHOR), Mehra, Shefali¹ (AUTHOR), Taylor, Justin¹ (AUTHOR) jxt1091@miami.edu

Publikováno v: Cells (2073-4409). Aug2024, Vol. 13 Issue 16, p1392. 15p.